+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD



Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD



International Journal of Chronic Obstructive Pulmonary Disease 10: 775-789



Chronic obstructive pulmonary disease (COPD) and asthma are common airway disorders characterized by chronic airway inflammation and airflow obstruction, and are a leading cause of morbidity and mortality in the People's Republic of China. These two diseases pose a high economic burden on the family and the whole of society. Despite evidence-based Global Initiative for Chronic Obstructive Lung Disease and Global Initiative for Asthma guidelines being available for the diagnosis and management of COPD and asthma, many of these patients are not properly diagnosed or managed in the People's Republic of China. The value of combination therapy with inhaled corticosteroids and long-acting β2-agonists has been established in the management of asthma and COPD globally. Combinations of inhaled corticosteroids and long-acting β2-agonists such as fluticasone and salmeterol, have been shown to be effective for improving symptoms, health status, and reducing exacerbations in both diseases. In this review, we discuss the efficacy and safety of this combination therapy from key studies, particularly in the People's Republic of China.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791327

Download citation: RISBibTeXText

PMID: 25926729

DOI: 10.2147/COPD.S80656


Related references

Comparative efficacy of combination of fluticasone and salmeterol; fluticasone, salmeterol and montelukast; fluticasone, salmeterol, and levocetirizine in moderate persistent asthma: A study of 120 patients. Chest 132(4): 512a-1, 2007

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial. Chest 144(4): 1222-1229, 2014

Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. Family Practice 24(2): 181-188, 2007

Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database. Physician and Sportsmedicine 38(4): 19-27, 2011

The salmeterol/fluticasone propionate dry powder combination Diskus has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma. Journal of Allergy & Clinical Immunology 103(1 PART 2): S132, 1999

Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 5: 179-187, 2010

Fluticasone propionate/salmeterol diskus combination product provides superior asthma control compared with fluticasone propionate and salmeterol alone in patients previously receiving PRN short-acting beta2-agonists alone. Journal of Allergy & Clinical Immunology 109(1 Supplement): S245, 2002

A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination. European Annals of Allergy and Clinical Immunology 35(9): 356-362, 2004

An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes. Current Medical Research and Opinion 24(11): 3141-3148, 2008

Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy. Journal of Allergy and Clinical Immunology. in Practice 4(5): 884-889, 2017

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2008(3): Cd004106, 2008

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2012(12): Cd004106, 2012

Fixed combination of salmeterol and fluticasone. A mile stone in asthma therapy. Mmw Fortschritte der Medizin 144(10): 54-54, 2002

Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece. Value in Health 18(7): A500, 2015

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Chest 132(6): 1756-1763, 2007